Whalesbook
Sector Ki Growth Toh Solid Lag Rahi Hai!
PL Capital ka analysis kaafi positive hai India ke healthcare sector ke liye Q4 FY26 ke liye. Agar sab theek raha toh EBITDA mein 18% ka year-over-year jump dekhne ko mil sakta hai! Ye growth kyu aayegi? Elective procedures badhenge, ARPOB (Average Revenue Per Occupied Bed) improve hoga, aur naye beds bhi add ho rahe hain. Overall sector revenue FY26 mein 16-18% tak grow kar sakta hai.
Top Companies Aur Unke Numbers
Fortis Healthcare, Max Healthcare Institute, HCG, aur Rainbow Children's Medicare jaise stocks par nazar rakho, ye top picks hain. Fortis ka P/E ratio around 65x hai aur market cap ₹64,000 Cr ke aas paas. FY25 mein revenue 12.88% badh kar ₹77.86 billion hua tha, aur EPS 29.28% jump kiya. Max Healthcare ka market cap ₹92,000 Cr se zyada hai. FY25 mein revenue 30.01% badh kar ₹70.28 billion hua, but earnings growth sirf 1.72% raha. Rainbow ka market cap ₹12,700 Cr ke range mein hai, P/E 40s-50s mein. HCG ka P/E toh 263x se 400x+ hai, jo high growth expectations dikhata hai, par profits kam ho rahe hain aur debt bhi hai.
India Ka Hospital Market Expand Ho Raha Hai!
Indian hospital market next tak, matlab 2034 tak, USD 364.55 billion tak pahunch jayega, 7.30% CAGR se grow karte hue. ARPOB growth pehle 4-6% lag raha tha FY25 ke liye, but recent data mein major chains ke liye 23% ka surge dikha hai 2024-25 mein. Demand drivers like non-communicable diseases aur health insurance penetration bhi strong hain. Hospital groups 34,000 naye beds add karne ka plan kar rahe hain.
Par, Yahan Hai Asli Risk!
Ab aata hai main drama! Middle East mein jo tensions badh rahi hain na, usse medical tourism par bahut bura impact pada hai. Patient inflow 50% se 75% tak gira hai. Fortis ko hi dekh lo, March mein revenue par 15-20% ka impact aa sakta hai, kyuki Middle East se unka 30% international business aata hai. Phir naye hospitals kholna bhi ek challenge hai. Initial operating costs zyada ho sakte hain. Specialized medical services ka cost bhi badh raha hai aur price regulations ka bhi risk hai. Max Healthcare ke Q3 FY26 results bhi analyst expectations se kam the, jo execution challenges dikhata hai.
Aage Kya?
Analysts ka outlook cautiously optimistic hai. Fortis ke liye annual earnings growth 29.1% aur revenue growth 15.8% predict kiya gaya hai. Par woh geopolitical instability aur execution challenges ko ignore nahi kar sakte. Sector ka performance in sab risks ko handle karne par depend karega.